These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12466972)

  • 1. Stable and unstable pools of Myc protein exist in human cells.
    Tworkowski KA; Salghetti SE; Tansey WP
    Oncogene; 2002 Dec; 21(55):8515-20. PubMed ID: 12466972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
    J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple cell-type-specific elements regulate Myc protein stability.
    Herbst A; Salghetti SE; Kim SY; Tansey WP
    Oncogene; 2004 May; 23(21):3863-71. PubMed ID: 15021906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic control of the oncoprotein transcription factor Myc.
    Thomas LR; Tansey WP
    Adv Cancer Res; 2011; 110():77-106. PubMed ID: 21704229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
    Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degrasyn activates proteasomal-dependent degradation of c-Myc.
    Bartholomeusz G; Talpaz M; Bornmann W; Kong LY; Donato NJ
    Cancer Res; 2007 Apr; 67(8):3912-8. PubMed ID: 17440106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
    D'Agnano I; Valentini A; Gatti G; Chersi A; Felsani A
    J Cell Physiol; 2007 Jan; 210(1):72-80. PubMed ID: 16998799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc-regulated microRNAs modulate E2F1 expression.
    O'Donnell KA; Wentzel EA; Zeller KI; Dang CV; Mendell JT
    Nature; 2005 Jun; 435(7043):839-43. PubMed ID: 15944709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
    McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
    J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
    Habel ME; Lemieux R; Jung D
    J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of myc:max in the control of cell proliferation and tumorigenesis.
    Hurlin PJ; Dezfouli S
    Int Rev Cytol; 2004; 238():183-226. PubMed ID: 15364199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of essential somatic cell cycle regulatory protein expression and implied activity occurs at the second to third cell division in mouse preimplantation embryos.
    Xie Y; Sun T; Wang QT; Wang Y; Wang F; Puscheck E; Rappolee DA
    FEBS Lett; 2005 Jan; 579(2):398-408. PubMed ID: 15642350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N; Hill AD; Young LS
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation.
    Yu M; Schreek S; Cerni C; Schamberger C; Lesniewicz K; Poreba E; Vervoorts J; Walsemann G; Grötzinger J; Kremmer E; Mehraein Y; Mertsching J; Kraft R; Austen M; Lüscher-Firzlaff J; Lüscher B
    Oncogene; 2005 Mar; 24(12):1982-93. PubMed ID: 15674325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.